During a recent earnings call, the CEO of Axonics Modulation Technologies (NASDAQ: AXNX) offered an enthusiastic outlook for the company's recently launched bladder-control device, r-SNM.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,